申请人:Clements Matthew J.
公开号:US20090239876A1
公开(公告)日:2009-09-24
The present invention relates to substituted 4-hydroxypyrimidine-5-carboxamides useful as HIF prolyl hydroxylase inhibitors to treat anemia and like conditions.
本发明涉及用作HIF脯氨酸羟化酶抑制剂以治疗贫血和类似疾病的取代4-羟基嘧啶-5-羧酰胺。